KWA
TEVA icon

Kingswood Wealth Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Kingswood Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$342K Buy
10,083
+1,349
+15% +$44.9K 0.01% 728
2026
Q1 		$263K Sell
8,734
-2,295
-21% -$73.8K 0.01% 767
2025
Q4 		$344K Sell
11,029
-4,143
-27% -$102K 0.02% 635
2025
Q3 		$306K Buy
+15,172
New +$266K 0.02% 621

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Kingswood Wealth Advisors's TEVA Position: Q2 2026 in Review

Kingswood Wealth Advisors increased its Teva Pharmaceuticals (TEVA) stake by 15% in Q2 2026, buying an estimated $44.9K and bringing the position to 10,083 shares worth $342K. The position accounts for 0.01% of the portfolio, ranked #728.

Kingswood Wealth Advisors first reported a position in TEVA in Q3 2025 and has held it in 4 quarters since. The position peaked at $344K in Q4 2025. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Kingswood Wealth Advisors held 10,083 shares of Teva Pharmaceuticals worth $342K as of Q2 2026.
  • Kingswood Wealth Advisors bought 1,349 Teva Pharmaceuticals shares in Q2 2026, an estimated $44.9K.
  • Teva Pharmaceuticals made up 0.01% of Kingswood Wealth Advisors's portfolio in Q2 2026, its #728 holding.
  • Kingswood Wealth Advisors first reported a position in Teva Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Kingswood Wealth Advisors's Teva Pharmaceuticals position peaked at $344K in Q4 2025.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Kingswood Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.